Explore
13D/13G Activist Filings
119,210 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | EOLS | EVOLUS, INC. | Nantahala Capital Management, LLC | 13G/A | 8.8% | 5.7M |
| Nov 14, 2025 | OP | OceanPal Inc. | Arena Investors, LP | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | RVYL | RYVYL Inc. | Arena Investors, LP | 13G/A | 10.0% | 3.5M |
| Nov 14, 2025 | ZNB | Zeta Network Group | Arena Investors, LP | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | N/A | Rubico Inc. | Arena Investors, LP | 13G | 8.1% | 1.6M |
| Nov 14, 2025 | HCAT | Health Catalyst, Inc. | First Light Asset Management, LLC | 13G/A | 18.9% | 13.4M |
| Nov 14, 2025 | AIFF | Firefly Neuroscience, Inc. | Arena Investors, LP | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | EB | EVENTBRITE, INC. | Nantahala Capital Management, LLC | 13G/A | 8.4% | 6.8M |
| Nov 14, 2025 | EHTH | EHEALTH, INC. | Nantahala Capital Management, LLC | 13G | 5.8% | 1.8M |
| Nov 14, 2025 | NVNO | enVVeno Medical Corporation | Nantahala Capital Management, LLC | 13G/A | 3.5% | 689K |
| Nov 14, 2025 | ASTL | Algoma Steel Group Inc. | MMCAP International Inc. SPC | 13G/A | 7.7% | 8.1M |
| Nov 14, 2025 | DRIO | DarioHealth Corp. | Nantahala Capital Management, LLC | 13G/A | 10.0% | 569K |
| Nov 14, 2025 | N/A | Western Uranium & Vanadium Corp. | MMCAP International Inc. SPC | 13G/A | 8.8% | 6.0M |
| Nov 14, 2025 | XFOR | X4 PHARMACEUTICALS, INC | Nantahala Capital Management, LLC | 13G | 10.0% | 2.2M |
| Nov 14, 2025 | ARMN | Aris Mining Corporation | MMCAP International Inc. SPC | 13G/A | 8.1% | 16.4M |
| Nov 14, 2025 | HIPO | Hippo Holdings Inc. | Lennar Corporation | 13D/A | 8.6% | 2.2M |
| Nov 14, 2025 | CDTX | Cidara Therapeutics, Inc. | Commodore Capital LP | 13G/A | 2.0% | 585K |
| Nov 14, 2025 | VSTM | Verastem, Inc. | Nantahala Capital Management, LLC | 13G/A | 7.1% | 4.6M |
| Nov 14, 2025 | EU | enCore Energy Corp. | MMCAP International Inc. SPC | 13G/A | 8.3% | 16.6M |
| Nov 14, 2025 | NDRA | ENDRA Life Sciences Inc. | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 3.0% | 36K |
| Nov 14, 2025 | ANAB | AnaptysBio Inc. | First Light Asset Management, LLC | 13G/A | 2.8% | 771K |
| Nov 14, 2025 | RDAG | Republic Digital Acquisition Co | Meteora Capital, LLC | 13G | 7.8% | 2.4M |
| Nov 14, 2025 | DXLG | DESTINATION XL GROUP, INC. | Nantahala Capital Management, LLC | 13G | 8.4% | 4.5M |
| Nov 14, 2025 | CMPS | COMPASS Pathways plc | Nantahala Capital Management, LLC | 13G/A | 3.6% | 3.5M |
| Nov 14, 2025 | VTGN | VISTAGEN THERAPEUTICS, INC. | Nantahala Capital Management, LLC | 13G/A | 10.0% | 3.2M |
| Nov 14, 2025 | EPRX | Eupraxia Pharmaceuticals Inc. | Robert Disbrow | 13G/A | 7.0% | 3.6M |
| Nov 14, 2025 | ETSY | ETSY, INC. | Holocene Advisors, LP | 13G/A | 3.1% | 3.1M |
| Nov 14, 2025 | MASS | 908 Devices Inc. | First Light Asset Management, LLC | 13G | 9.8% | 3.6M |
| Nov 14, 2025 | UNCY | UNICYCIVE THERAPEUTICS, INC. | Nantahala Capital Management, LLC | 13G/A | 10.0% | 1.9M |
| Nov 14, 2025 | AVR | Anteris Technologies Global Corp. | Nantahala Capital Management, LLC | 13G | 5.3% | 1.9M |
| Nov 14, 2025 | N/A | Youxin Technology Ltd | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 1.6% | 67K |
| Nov 14, 2025 | THTX | Theratechnologies Inc. | Nantahala Capital Management, LLC | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | TLSI | TRISALUS LIFE SCIENCES, INC. | Nantahala Capital Management, LLC | 13G/A | 4.1% | 2.0M |
| Nov 14, 2025 | ASPS | ALTISOURCE PORTFOLIO SOLUTIONS S.A. | Nantahala Capital Management, LLC | 13G | 8.4% | 1.0M |
| Nov 14, 2025 | THRD | THIRD HARMONIC BIO, INC. | Nantahala Capital Management, LLC | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | TYRA | Tyra Biosciences, Inc. | Commodore Capital LP | 13G/A | 6.3% | 3.4M |
| Nov 14, 2025 | AXGN | Axogen, Inc. | First Light Asset Management, LLC | 13G/A | 12.2% | 5.6M |
| Nov 14, 2025 | FNKO | Funko, Inc. | COOPER CREEK PARTNERS MANAGEMENT LLC | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | COGT | Cogent Biosciences, Inc. | Paradigm BioCapital Advisors LP | 13G/A | 2.3% | 3.2M |
| Nov 14, 2025 | AGIO | Agios Pharmaceuticals, Inc. | Paradigm BioCapital Advisors LP | 13G/A | 4.9% | 2.9M |
| Nov 14, 2025 | FLWS | 1 800 FLOWERS COM INC | Nantahala Capital Management, LLC | 13G/A | 9.2% | 3.4M |
| Nov 14, 2025 | CDTX | Cidara Therapeutics, Inc. | Paradigm BioCapital Advisors LP | 13G/A | 3.3% | 961K |
| Nov 14, 2025 | WOK | WORK Medical Technology Group LTD | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | SVRA | Savara Inc. | Nantahala Capital Management, LLC | 13G | 5.1% | 8.8M |
| Nov 14, 2025 | RAPT | RAPT Therapeutics, Inc. | Nantahala Capital Management, LLC | 13G/A | 3.8% | 623K |
| Nov 14, 2025 | SOS | SOS Ltd | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 0.2% | 1.9M |
| Nov 14, 2025 | RAIN | Rain Enhancement Technologies Holdco, Inc. | Meteora Capital, LLC | 13G/A | 5.7% | 429K |
| Nov 14, 2025 | LENZ | LENZ Therapeutics, Inc. | Paradigm BioCapital Advisors LP | 13G/A | 3.8% | 1.1M |
| Nov 14, 2025 | WRBY | Warby Parker Inc. | Durable Capital Partners LP | 13G/A | 8.3% | 8.8M |
| Nov 14, 2025 | QNCX | Quince Therapeutics, Inc. | Nantahala Capital Management, LLC | 13G/A | 10.0% | 5.6M |